Adam K. Simpson, Chief Executive Officer at Icosavax, Inc. (ICVX), sold 21,532 shares at $15.29 ($229K) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Scheduled sale ($229k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,532 | $0 | 0.0% |
| 2 | $15.29 | 15,000 | $229K | 100.0% |
| Total | $10.65 avg | 21,532 | $229K | 100% |
| Filing → |
| ICVX | SELL | 2023-08-01 | $209K | — | Filing → |
| ICVX | SELL | 2023-02-15 | $160K | — | Filing → |
| ICVX | SELL | 2022-12-23 | $1.2M | — | Filing → |